Advances in New Modalities: Biologics and Large Molecules

This session welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include biologics and other large molecules, oligos, peptides, ADCs, gene therapy, and other new modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish, and finished device/delivery.